An industry-leading approach
We support member health and deliver lower overall costs by focusing on a smarter formulary, biosimilar adoption, effective condition-management tools and more. This commitment to improving outcomes and lowering drug prices means our strategy constantly evolves to meet your changing needs.
Helping you manage pharmacy costs
Better pricing,
greater discounts
We negotiate with drug manufacturers to lower Rx and specialty therapy costs. Customized plans are designed to adapt as new treatments become available, reducing costly changes.
Ensuring proper dosage and timing
Our solutions provide cost-effective, clinically appropriate coverage without compromising care. So you can ensure your members get the right treatment while controlling spend.
Staying ahead of the market
Licensed pharmacists and analysts from our Clinical Pipeline Services team provide insights on drugs currently under development. This helps anticipate costs and informs strategy.
Transforming pharmacy
As the first PBM to implement biosimilars into our formulary, we’re providing members with clinically effective and affordable specialty Rx alternatives — and driving the market forward.
Helping members save on prescriptions
Our Cost Saver tool compares out-of-pocket drug costs with available discount program prices and applies the lowest price right at checkout. So members can automatically save on their medications, right at the pharmacy counter.
Multiple solutions, major savings
$4.3B
forecasted in client savings* with our 2025 managed formularies
52%
less client spend in 2024* due to formulary, quantity limit, and other utilization management strategies
~86%
of members that chose preferred biosimilars* had a $0 out-of-pocket cost in 2024
Managing the cost of GLP-1s
GLP-1s can be a transformative part of weight management. As demand grows and the market evolves, we’re finding ways to help you support members while balancing costs.
What’s new in the pharmacy benefits world?
Find out what’s new and next so you can stay on top of what you need to keep members healthier and reach your goals.
-
*FOR $4.3B FORECASTED IN CLIENT SAVINGS SOURCE: CVS Health, 2024. Client savings are determined using cumulative value over a 5-year period (Upcoming year, current year, and three prior years).
-
*FOR 52% LESS CLIENT SPEND IN 2024 SOURCE: CVS Health Analytics, 2025. CVS Commercial Health Plan clients Jan 2024 – Dec 2024. Total $ savings by program is for all commercial clients with adoption. Savings taken from Non-specialty PA, SGM, QL and Rebates. Standard and Custom criteria both included for PA/SGM savings.
-
*FOR ~86% OF MEMBERS THAT CHOSE PREFERRED BIOSIMILARS SOURCE: CVS Health Analytics, April 1, 2024 – December 31, 2024. CVS Commercial clients.